Open AccessA case of fetal bradycardia following dexmedetomidine bolus
Author(s) -
Menachem M. Weiner,
Robert Dobbin Chow,
Benjamin Salter
Publication year - 2014
Publication title -
journal of obstetric anaesthesia and critical care/journal of obstetric anaesthesia and critial care
Language(s) - English
Resource type - Journals
eISSN - 2249-9539
pISSN - 2249-4472
DOI - 10.4103/2249-4472.143876
Subject(s) - dexmedetomidine , bradycardia , medicine , sedation , anesthesia , bolus (digestion) , agonist , intravenous bolus , fetus , heart rate , pregnancy , blood pressure , receptor , biology , genetics
We report a case of fetal bradycardia immediately following the maternal administration of an intravenous bolus of dexmedetomidine for transesophageal echocardiography. Dexmedetomidine, a central acting selective alpha-2 agonist is increasingly being used for sedation. Little is known regarding placental transfer of dexmedetomide with most reports suggesting minimal transfer. A case of fetal bradycardia resulting from its administration has not been previously reported